β-HPC led to a reduction in SREBP-1 expression, as well as in the number and size of fat vacuoles and also triglyceride levels in all animals with NASH, suggesting that β-HPC might modulate SREBP-1 expression and activation. Here, SREBF1 is linked to metabolic dysfunction-associated steatohepatitis.